Population-wide immune responses to SARS-CoV-2: Insights from quantifying the antibody response
Watch this on-demand webinar to discover a new approach to profiling antibody responses by quantifying affinity and concentration
Watch this on-demand webinar to discover a new approach to profiling antibody responses by quantifying affinity and concentration
The expanded agreement grants Iksuda access to LegoChem Biosciences’ next generation ADC platform for up to six targets
Learn more about the efficient and reproducible multiplex immunoassays set to change the way COVID-19 researchers profile antibody response
The research also found the presence of detectable viral RNA in blood in COVID-19 patients is a strong predictor of mortality
Infectious disease scientist Dr. Padmapriya Banada explores the potential of cycle threshold values and reveals her melt-based assay alternative
This multi-session event will take you on a weekly path of discovery, featuring the latest in IHC antibodies, histology troubleshooting techniques, case studies in pathology, and more
The test will be widely available to individuals through pharmacies and other locations in accordance with local guidelines and testing strategies
Guest editorial: Learn how clinicians can utilize diagnostic information to make decisions when examining suspected SARS-CoV-2 patients
Explore expert webinars, free downloads, latest methods, and much more to help support biopharmaceutical research
The fast time-to-result includes a pretreatment process to inactivate the virus as a safeguard for laboratory staff handling the samples
Both new antibody tests help healthcare teams differentiate the cause of antibodies against SARS-CoV-2
The availability of an International Standard (IS) for antibodies facilitates the standardization of SARS-CoV-2 serological methods
The test offers 98.0% clinical sensitivity for samples with PCR Ct values up to 31
Reserve your place today for talks on topics ranging from food fraud, spatial infiltration and CRISPR to antibody and AAV gene therapies
The EBV panel can be used to rule out other acute infections, such as missed HIV infections